Correspondingly, ApoE4 carrier AD patients had higher AS risk than non-carriers (Beeri et al., 2006), signifying that ApoE4 carrier AD patients due to higher peripheral Aβ1–42 level is correlated with the severity of AS. The gene discussed is APOE; the disease is Alzheimer disease.